Related Experiment Videos
The serological response to papillomaviruses.
1Laboratory of Tumour Virus Epidemiology, The Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, S-17177, Sweden.
Seminars in Cancer Biology
|March 14, 2000
Summary
Human papillomavirus (HPV) antibody responses are crucial for immunity and cancer prediction. HPV serology aids in understanding HPV infection spread, natural history, and cancer risks.
Area of Science:
- Immunology
- Epidemiology
- Oncology
Background:
- Antibody responses to human papillomaviruses (HPV) are critical for protective immunity.
- HPV serology serves as a vital epidemiological tool for assessing past and present infections.
- It is also used for predicting HPV-associated cancers and precursor lesions.
Purpose of the Study:
- To review the assay of antibody responses to the HPV capsid.
- To explore the utility of HPV serology as a marker of cumulative HPV exposure.
- To survey the application of HPV seroepidemiology in understanding HPV infection dynamics and cancer risks.
Main Methods:
- Review of literature on HPV antibody assays.
- Analysis of studies utilizing HPV serology for epidemiological surveys.
- Examination of data linking HPV exposure to cancer development.
Main Results:
- Antibody responses to the HPV capsid are a key indicator of protective immunity.
- HPV serology effectively tracks cumulative HPV exposure.
- Seroepidemiological data illuminate HPV spread, natural history, and cancer associations.
Conclusions:
- Assessing HPV antibody responses is essential for understanding immunity.
- HPV serology is a powerful tool for epidemiological research and cancer risk prediction.
- HPV exposure is linked to an increased risk of several human cancers.